SCHEMBL7477208

SCHEMBL7477208

CCS(=O)(=O)N(CC(=O)NCCc1ccccn1)C1CC(C)(C)Oc2ccc(F)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.41
KCNA5 P22460 1/20 0.39
TRPV1 Q8NER1 4/20 0.39
KCNE1 P15382 3/20 0.38
KCNQ1 P51787 3/20 0.38
HSD11B1 P28845 1/20 0.38
HTT P42858 2/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
GAA P10253 1/20 0.37
TSHR P16473 1/20 0.36
PKM P14618 1/20 0.36
CYP3A4 P08684 1/20 0.36
NPC1 O15118 1/20 0.36
PDGFRB P09619 1/20 0.35
KIT P10721 1/20 0.35
KDR P35968 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7473827 0.91 KCNA5 (0.38) HSD17B10KCNA5TRPV1KCNE1KCNQ1
SCHEMBL7472708 0.88 MAPT (0.48) KCNA5TRPV1KCNE1KCNQ1HTT
SCHEMBL7469462 0.88 TRPV1 (0.38) TRPV1KCNE1KCNQ1HTTALDH1A1
SCHEMBL7474303 0.86 TRPV1 (0.46) KCNA5TRPV1KCNE1KCNQ1HTT
SCHEMBL7473315 0.86 TRPV1 (0.37) TRPV1KCNE1KCNQ1HTTALDH1A1
SCHEMBL7464041 0.85 SMN1; SMN2 (0.46) TRPV1KCNE1KCNQ1GAACYP3A4
SCHEMBL7470001 0.84 KCNE1 (0.42) TRPV1KCNE1KCNQ1CYP3A4
SCHEMBL4621983 0.83 KCNE1 (0.45) HSD17B10TRPV1KCNE1KCNQ1MAPT
SCHEMBL14256398 0.83 KCNE1 (0.45) HSD17B10TRPV1KCNE1KCNQ1MAPT
SCHEMBL4621868 0.81 KMT2A (0.42) TRPV1KCNE1KCNQ1HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0905131-B1 Sulfonamid-substituted chromans, process for their preparation, their use as medicine, and pharmaceutical preparation containing them AVENTIS PHARMA GMBH (DE) 2002-04-10 EP disclosed
EP-0905131-A1 Sulfonamid-substituted chromans, process for their preparation, their use as medicine, and pharmaceutical preparation containing them Hoechst Marion Roussel Deutschland GmbH (DE) 1999-03-31 EP disclosed